Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
61,129.11 +829.19 (+1.38%) CMC Crypto 200
1,261.13 -96.88 (-7.13%)
Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)
Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
At close: 03:04PM CST
| Previous close | 34.79 |
| Open | 33.63 |
| Bid | 34.69 x 0 |
| Ask | 34.74 x 0 |
| Day's range | 34.35 - 35.10 |
| 52-week range | 21.60 - 35.49 |
| Volume | |
| Avg. volume | 16,801,769 |
| Market cap | 55.559B |
| Beta (5Y monthly) | 0.04 |
| PE ratio (TTM) | 20.05 |
| EPS (TTM) | 1.73 |
| Earnings date | N/A |
| Forward dividend & yield | 0.62 (1.78%) |
| Ex-dividend date | 15 May 2023 |
| 1y target est | 41.38 |
- Reuters
Merck discontinues some cancer drug development with China's Sichuan Kelun
Chinese drugmaker Sichuan Kelun Pharmaceutical Co said on Monday that Merck & Co Inc was abandoning the joint development of two candidate cancer drugs which have yet to start clinical trials. Representatives for Merck did not immediately respond to a Reuters request for comment. The move comes days after Merck said it would pay Daiichi Sankyo $5.5 billion to jointly develop three of its candidate cancer drugs in a deal that could be worth up to $22 billion for the Japanese firm.
© 2024 Yahoo. All rights reserved.